We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

155 hedge funds and large institutions have $1.34B invested in NPS PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 155 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $9.72M | Put options by funds: $5.15M

Holders
155
Holders Change
+155
Holders Change %
% of All Funds
5.06%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
155
Increased
Reduced
Closed
Calls
$9.72M
Puts
$5.15M
Net Calls
+$4.57M
Net Calls Change
+$4.57M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$229M +$210M +15,184,127 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$115M +$105M +7,612,155 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$81M +$74.3M +5,364,426 New
CWAM
4
Columbia Wanger Asset Management
Illinois
$78.6M +$72.1M +5,207,000 New
BFA
5
BlackRock Fund Advisors
California
$49M +$45M +3,244,929 New
TI
6
Turner Investments
Pennsylvania
$48.7M +$44.7M +3,222,836 New
State Street
7
State Street
Massachusetts
$42.2M +$38.7M +2,792,577 New
ORI
8
Oak Ridge Investments
Illinois
$42M +$38.6M +2,782,714 New
BIT
9
BlackRock Institutional Trust
California
$40.7M +$37.4M +2,696,138 New
SAM
10
Sectoral Asset Management
Quebec, Canada
$34.8M +$31.9M +2,302,428 New
RIM
11
RS Investment Management
California
$29.7M +$27.3M +1,970,092 New
CCM
12
Consonance Capital Management
New York
$27.8M +$25.5M +1,839,263 New
BC
13
Broadfin Capital
New York
$25.6M +$23.5M +1,696,754 New
Millennium Management
14
Millennium Management
New York
$23.4M +$21.5M +1,548,718 New
NCGI
15
Next Century Growth Investors
Minnesota
$21.7M +$19.9M +1,438,562 New
Northern Trust
16
Northern Trust
Illinois
$21.2M +$19.4M +1,402,336 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$20.3M +$18.6M +1,344,451 New
Lord, Abbett & Co
18
Lord, Abbett & Co
New Jersey
$18.4M +$16.9M +1,218,580 New
EA
19
Emerald Advisers
Pennsylvania
$18M +$16.5M +1,193,198 New
Wells Fargo
20
Wells Fargo
California
$17.7M +$16.2M +1,168,416 New
CCM
21
Century Capital Management
Massachusetts
$16.6M +$15.2M +1,098,272 New
Deutsche Bank
22
Deutsche Bank
Germany
$16.3M +$14.9M +1,076,863 New
JHIU
23
Janus Henderson Investors US
Colorado
$15.7M +$14.4M +1,036,709 New
Invesco
24
Invesco
Georgia
$14.4M +$13.2M +953,956 New
Two Sigma Investments
25
Two Sigma Investments
New York
$11.4M +$10.5M +756,120 New

NPSP Hedge Fund Activity: Q2 2013 in Review

155 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2013, worth a combined $1.34B.

Buyers outnumbered sellers: 155 funds opened new NPSP positions and 0 closed out — a net gain of 155 holders — while 0 added to existing stakes and 0 trimmed.

  • 155 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.34B of NPS PHARMACEUTICALS INC stock for Q2 2013.
  • 155 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +155 holders.

Based on aggregated 13F filings for Q2 2013.